2009
DOI: 10.1002/pbc.22328
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive Imaging Surrogate of Angiogenesis in Osteosarcoma

Abstract: This study suggests an important role of DCE-MRI as a noninvasive imaging surrogate of tumor angiogenesis in osteosarcoma based on visual inspection of TIC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
27
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(28 citation statements)
references
References 16 publications
1
27
0
Order By: Relevance
“…No precautions were taken to avoid bowel movements, nor was the administration of butylscopolamine, dicyclomine, glucagon or similar drugs carried out, because a volumetric analysis was performed thus minimizing errors due to caused voxel misalignments. The semi-quantitative approach used takes inspiration from studies on breast and osteosarcoma tumours, where leaky capillaries associated with tumour neovascularization determine rapid gadolinium tissue uptake and early washout, which correlate with VEGF and MVD [10][11][12]. However, being rapid growing, colorectal carcinomas similar to breast tumour and most malignant tumours for their biological characteristics, using their contrast kinetics on MRI can be depicted by DCE-MRI [8][9][10][11].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…No precautions were taken to avoid bowel movements, nor was the administration of butylscopolamine, dicyclomine, glucagon or similar drugs carried out, because a volumetric analysis was performed thus minimizing errors due to caused voxel misalignments. The semi-quantitative approach used takes inspiration from studies on breast and osteosarcoma tumours, where leaky capillaries associated with tumour neovascularization determine rapid gadolinium tissue uptake and early washout, which correlate with VEGF and MVD [10][11][12]. However, being rapid growing, colorectal carcinomas similar to breast tumour and most malignant tumours for their biological characteristics, using their contrast kinetics on MRI can be depicted by DCE-MRI [8][9][10][11].…”
Section: Discussionmentioning
confidence: 99%
“…The circumferential resection margin was examined by sampling a 1-mm thick slice [22] and was defined as positive if the tumour residuals were found ≤1 mm from the margin. Lymph nodes were examined by the manual dissection method [11]. The mandard TRG scoring system was used [23]: TRG 1 means a complete response with absence of residual cancer and fibrosis extending through the wall.…”
Section: Surgical Approach and Evaluation Of Pathological Responsementioning
confidence: 99%
See 1 more Smart Citation
“…Perfusion imaging sequences are used for providing insight into the vascularity of a tumor and can be accomplished with a variety of pulse sequences, including DW sequences (31), unenhanced perfusion sequences (60,61), and the most commonly implemented dynamic contrastenhanced sequence (62)(63)(64)(65)(66)(67)(68)(69)(70)(71)(72)(73)(74)(75)(76)(77)(78)(79)(80). Perfusion imaging with dynamic contrast-enhanced MR imaging is the most popular technique at this time, since other techniques have not been well explored for musculoskeletal tumors.…”
Section: Perfusion Mr Imaging (Functional Technique)mentioning
confidence: 99%
“…FDG-PET and PET-CT may play an important role in determining the metabolic rates of osteosarcoma, guiding biopsy, detecting local recurrence in amputation stumps, evaluating patients with suspected metastatic disease, monitoring response to therapy and assessing for prognosis and differentiating viable sarcoma from post treatment changes. [77,78] FDG uptake in osteosarcoma has a good correlation with histological grading or tumor aggressiveness. Bastiaannet and coworkers conducted a meta-analysis of 29 clinical studies on the diagnostic value of FDG-PET in the detection, grading, and therapy response of soft tissue and bone sarcomas.…”
Section: Bone Tumorsmentioning
confidence: 97%